Assessment of histologic features and biomarkers of breast carcinoma associated with pathologic complete response to neoadjuvant chemotherapy

被引：0
|
作者：
Gao, X. [1 ]
Khan, Q. [1 ]
Davis, M. [1 ]
Connor, C. [1 ]
Tawfik, O. W. [1 ]
Thomas, P. A. [1 ]
Fan, F. [1 ]
机构：
[1] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA
来源：
MODERN PATHOLOGY | 2007年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
124
引用
收藏
页码：32A / 32A
页数：1
相关论文
共 50 条
  • [21] Predictive biomarkers of breast cancer response to neoadjuvant chemotherapy and their relationship to pathologic assessment of residual disease
    Marginean, EC
    Puzstai, L
    Hortobagyi, GN
    Symmans, WF
    MODERN PATHOLOGY, 2006, 19 : 33A - 34A
  • [22] Association of higher axillary pathologic complete response rate with breast pathologic complete response after neoadjuvant chemotherapy
    Zhu, Jiujun
    Li, Jianbin
    Fan, Zhimin
    Wang, Haibo
    Zhang, Jianguo
    Yin, Yongmei
    Fu, Peifen
    Geng, Cuizhi
    Jin, Feng
    Jiang, Zefei
    Liu, Zhenzhen
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (16)
  • [23] Bisphosphonates and Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer
    Gregor, M. Chavez-Mac
    Brown, E. N.
    Lei, X.
    Hsu, L.
    Meric-Bernstam, F.
    Litton, J.
    Mittendorf, E. A.
    Valero, V.
    Hortobagyi, G. N.
    Gonzalez-Angulo, A. M.
    CANCER RESEARCH, 2010, 70
  • [24] Diabetes Mellitus and Metformin Are Not Associated with Complete Pathologic Response Following Neoadjuvant Chemotherapy for Breast Cancer
    Hassinger, T.
    Berger, A.
    Christopher, A.
    Knisely, A.
    Mehaffey, J.
    Witmer, H.
    Lazar, M.
    Tsangaris, T.
    Brenin, D.
    Schreon, A.
    Showalter, S. L.
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 : S105 - S105
  • [25] Histologic treatment effect may predict clinical and pathologic response to neoadjuvant chemotherapy in advanced breast carcinoma.
    Pernick, N
    Biernat, L
    Visscher, DW
    LABORATORY INVESTIGATION, 1999, 79 (01) : 29A - 29A
  • [26] Predictors of Pathologic Complete Response After Standard Neoadjuvant Chemotherapy in Triple-negative Breast Carcinoma
    Kraus, James A.
    Beriwal, Sushil
    Dabbs, David J.
    Ahrendt, Gretchen M.
    McGuire, Kandace P.
    Johnson, Ronald R.
    Badve, Preeti
    Puhalla, Shannon L.
    Bhargava, Rohit
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2012, 20 (04): : 334 - 339
  • [27] Change in tumor cellularity of breast carcinoma after neoadjuvant chemotherapy as a variable in the pathologic assessment of response
    Rajan, R
    Poniecka, A
    Smith, TL
    Yang, Y
    Frye, D
    Pusztai, L
    Fiterman, DJ
    Gal-Gombos, E
    Whitman, G
    Rouzier, R
    Green, M
    Kuerer, H
    Buzdar, AU
    Hortobagyi, GN
    Symmans, WF
    CANCER, 2004, 100 (07) : 1365 - 1373
  • [28] A nomogram based on clinicopathological features and serological indicators predicting breast pathologic complete response of neoadjuvant chemotherapy in breast cancer
    Yijun Li
    Jian Zhang
    Bin Wang
    Huimin Zhang
    Jianjun He
    Ke Wang
    Scientific Reports, 11
  • [29] A nomogram based on clinicopathological features and serological indicators predicting breast pathologic complete response of neoadjuvant chemotherapy in breast cancer
    Li, Yijun
    Zhang, Jian
    Wang, Bin
    Zhang, Huimin
    He, Jianjun
    Wang, Ke
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [30] Biomarkers Predicting Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer
    Li, Xiaoxian
    Krishnamurti, Uma
    Bhattarai, Shristi
    Klimov, Sergey
    Reid, Michelle
    Aneja, Ritu
    MODERN PATHOLOGY, 2016, 29 : 54A - 54A
12345